Sea Cucumber Compounds Targeting NF-κB in Cancer Treatment

Area of Science:

• Marine natural products
• Pharmacology
• Cancer biology

Background:

• Cancer poses a significant global health challenge with limited effective treatments.
• Nuclear factor kappa B (NF-κB) signaling is implicated in cancer promotion, progression, and drug resistance.
• Sea cucumber biocompounds exhibit potential anticancer properties, necessitating further investigation into their mechanisms and targets.

Purpose of the Study:

• To explore the anticancer mechanisms of sea cucumber-derived compounds targeting the NF-κB signaling pathway.
• To identify specific protein targets within the NF-κB network affected by these compounds.
• To evaluate the drug-likeness properties of active sea cucumber compounds.

Main Methods:

• Literature review and database analysis to identify proteins targeted by sea cucumber compounds within the NF-κB network.
• Bioinformatic analysis to map compound targets to relevant cancer-associated pathways.
• SwissADME prediction to assess the pharmacokinetic properties (druglikeliness) of identified active compounds.

Main Results:

• Sea cucumber compounds were found to interact with proteins central to the NF-κB signaling pathway.
• Database analysis revealed these compounds modulate multiple cancer-related pathways linked to NF-κB.
• SwissADME analysis indicated favorable druglikeliness properties for several active sea cucumber compounds.

Conclusions:

• Sea cucumber-derived compounds represent a promising source of novel anticancer therapeutics.
• Targeting the NF-κB pathway with these marine natural products offers a potential strategy for treating various cancers.
• The identified compounds warrant further investigation for clinical development as anticancer drugs.